| BTG Says FDA Accepts BLA Filing For Glucarpidase - RTT News |
|
|
RTT News The company noted that Glucarpidase is intended for reducing toxic methotrexate levels due to impaired renal function. High dose methotrexate chemotherapy is used to treat or prevent the recurrence of certain types of cancer such as leukaemia, |